- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00782873
Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients
Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients: Assessment of Cardiopulmonary Parameters
The purpose of this study is to evaluate the safety of propofol-based, gastroenterologist-administered sedation in severely obese patients (BMI≥35) undergoing upper endoscopy.
The investigators aim to test the hypothesis that it is safe to use balanced-propofol, gastroenterologist-administered sedation in obese patients.
Study Overview
Status
Conditions
Detailed Description
The purpose of this study is to evaluate the safety of propofol-based, gastroenterologist-administered sedation in severely obese patients (BMI≥35) undergoing upper endoscopy. We will use changes in pulmonary and hemodynamic parameters as the primary safety measure in this study. We will compare these results in 30 non-obese patients and in 30 obese patients.
The term balanced propofol sedation refers to using a low dose of propofol in combination with small amounts of an opioid and midazolam.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10075
- Research Associates of New York
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Undergoing an endoscopic esophagostroduodenoscopy (EGD)
- Capable of providing written informed consent and willing and able to comply with all procedures of the study
- Adults between the ages of 18 and 85 inclusive (and of legal age to consent)
- ASA score of I, II, or III
Exclusion Criteria:
- Severe acute illness that is not resolved or stabilized prior to enrollment. Study entry will be based on the investigator's judgment
- Need for sleep or narcotic analgesic medication on a continuous basis during the proceeding 6 months
- Pregnancy
- A history of drug addiction or alcohol abuse within the past 12 months. Alcohol can be consumed in moderation. The consumption of alcohol should be within the routine pattern for the individual before the study.
- A history of seizure disorder.
- Allergy to propofol, soy beans, or eggs.
- Prior history of difficult intubation.
- Prior history of severe complications during conscious sedation. Study entry will be based on the investigator's judgment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
obese subjects
BMI > 35
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
A change in mean arterial pressure (MAP) of 20% or more from baseline
Time Frame: during upper endoscopy
|
during upper endoscopy
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Episodes of bradycardia - pulse less than 50
Time Frame: during upper endoscopy
|
during upper endoscopy
|
ECG changes consistent with myocardial ischemia
Time Frame: during upper endoscopy
|
during upper endoscopy
|
Decrease in respiratory rate - change of 20% or more from baseline
Time Frame: during upper endoscopy
|
during upper endoscopy
|
Assess the dose of propofol, midazolam, and fentanyl necessary to achieve adequate sedation during upper endoscopy and compare the dose requirements of the obese and non-obese patient cohorts.
Time Frame: after all patients completed
|
after all patients completed
|
Compare the level of sedation between the obese and non-obese cohorts
Time Frame: after all patients completed
|
after all patients completed
|
compare patient satisfaction with endoscopic sedation in obese and non-obese cohorts
Time Frame: after all patients completed
|
after all patients completed
|
Compare time to sedation in the obese and non-obese cohorts
Time Frame: after all patients completed
|
after all patients completed
|
Oxygen desaturation
Time Frame: during upper endoscopy
|
during upper endoscopy
|
Apneic episodes
Time Frame: during upper endoscopy
|
during upper endoscopy
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lawrence B Cohen, MD, Research Associates of New York
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 424-02-08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted